logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 3-Methylaminop-iperidine Dihydrochloride CAS 127294-77-3

3-Methylaminop-iperidine Dihydrochloride CAS 127294-77-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 127294-77-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,T/T,D/P,MoneyGram,Western Union

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
White Solid
CAS NO::
127294-77-3
Molecular Formula::
C6H16Cl2N2
Molecular Weight::
187.11100
EINECS NO::
691-509-2
MDL NO::
MFCD00673143
Appearance::
White Solid
CAS NO::
127294-77-3
Molecular Formula::
C6H16Cl2N2
Molecular Weight::
187.11100
EINECS NO::
691-509-2
MDL NO::
MFCD00673143
3-Methylaminop-iperidine Dihydrochloride CAS 127294-77-3

Product Description:

Product Name: 3-Methylaminop-iperidine dihydrochloride CAS NO: 127294-77-3


Synonyms:

N-methylpiperidin-3-amine,dihydrochloride;

3-(Methylamino)p-iperidine dihydrochloride;


Chemical & Physical Properties:

Appearance: White solid

Assay :≥99.00%

Boiling Point: 253.7℃ at 760 mmHg

Melting Point: 199-200℃

Flash Point: 107.2℃

Vapor Pressure: 0.0143mmHg at 25℃


Safety Information:

RTECS: WN2817000

Safety Statements: S26; S36; S37/39

HS Code: 2933399090

WGK Germany: 3

Risk Statements: R22; R36/37/38

Hazard Codes: Xn; Xi


3-m-e-thylamine p-iperidine (1) is an important intermediate for the synthesis of fluoroquinolone antimicrobial balofloxacin. In the literature, 3-m-e-thylamine p-iperidine was obtained from γ-butyllactone through amination, hydrolysis, esterification, condensation with ethyl bromoacetate, cyclization, ester hydrolysis and decarboxylation, reductive amination and hydrodissociation of benzyl. The Chemicalbook grew rapidly and the total yield was low (only 11.5%). 3- methylaminopyridine (4) was prepared from 3- aminopyridine (2) by formylation and reduction with lithium aluminum hydride. Or 2 and triethyl orthoformate were condensed and reduced with sodium borohydride to obtain 4,4 and then reduced by Pd/C to obtain 3-methylamino-p-iperidine diacetate, the total yields were 16% and 32%, respectively.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.